Answers are grounded in this paper and cite their sources.
A case series evaluates colchicine's effectiveness for skin issues in immunoglobulin A vasculitis, suggesting clinical application.
Colchicine appears to be a safe and effective treatment for persistent, severe, or recurrent cutaneous manifestations of IgAV. These findings support its use in clinical practice and highlight the need for prospective controlled studies.
No takes yet. Share an insight, caveat, or question.
Barch et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: